LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Clarius Group, LLC's Holding History (CIK: 0001664214)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 399,168 Value ($000) $215 Avg Close — Range —
Q4 2024
Shares 399,168 Value ($000) $255 Avg Close — Range —
Q3 2024
Shares 399,168 Value ($000) $551 Avg Close — Range —
Q2 2024
Shares 399,168 Value ($000) $579 Avg Close — Range —
Q1 2024
Shares 399,168 Value ($000) $890 Avg Close — Range —
Q4 2023
Shares 399,168 Value ($000) $774 Avg Close — Range —
Q3 2023
Shares 399,168 Value ($000) $587 Avg Close — Range —
Q2 2023
Shares 399,168 Value ($000) $1,269 Avg Close — Range —
Q1 2023
Shares 16,404 Value ($000) $39 Avg Close — Range —
Q4 2022
Shares 16,404 Value ($000) $0 Avg Close — Range —
Q3 2022
Shares 16,404 Value ($000) $120 Avg Close — Range —
Q2 2022
Shares 16,404 Value ($000) $107 Avg Close — Range —
Q1 2022
Shares 16,404 Value ($000) $127 Avg Close — Range —
Q4 2021
Shares 16,404 Value ($000) $127 Avg Close — Range —